title: Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
authors.affiliation: Department of Human Biopathology, University La Sapienza, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: M
authors.initials: M
authors.lastname: Tribalto
authors.forename: G
authors.initials: G
authors.lastname: Avvisati
authors.forename: M
authors.initials: M
authors.lastname: Cantonetti
authors.forename: M T
authors.initials: MT
authors.lastname: Petrucci
authors.forename: M
authors.initials: M
authors.lastname: Boccadoro
authors.forename: A
authors.initials: A
authors.lastname: Pileri
authors.forename: F
authors.initials: F
authors.lastname: Marmont
authors.forename: L
authors.initials: L
authors.lastname: Resegotti
authors.forename: V
authors.initials: V
authors.lastname: Lauta
mesh_terms: D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use*
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins